SEC CIK 1645617
SCHLACKMAN SCOTT
Reported ownership across 1 company, sourced from SEC Form 4 filings and updated daily.
Current Positions
| Company | Shares Owned | As Of |
|---|---|---|
| MEDview stock → | 42,228.707 | 2026-05-26 |
Position History — MED
Reported shares owned immediately after each Form 4 transaction, over time.
Recent Filings — MED
| Date | Activity | Shares | Price | Owned After |
|---|---|---|---|---|
| 2026-05-26 | Grant / award | 11,680 | $0.00 | 42,228.707 |
| 2026-05-11 | Open-market buy | 2,500 | $12.53 | 30,548.707 |
| 2026-05-08 | Open-market buy | 2,500 | $12.65 | 28,048.707 |
| 2025-06-25 | Grant / award | 11,168 | $0.00 | 25,548.707 |
| 2024-06-20 | Grant / award | 6,596 | $0.00 | 14,380.707 |
| 2024-03-08 | Option exercise (derivative) | 1,300 | $0.00 | 0 |
| 2024-03-08 | Open-market sale | 2,753 | $39.46 | 7,784.707 |
| 2024-03-08 | Open-market sale | 1,300 | $39.41 | 10,537.707 |
| 2024-03-08 | Option exercise | 1,300 | $27.68 | 11,837.707 |
Source: SEC EDGAR Form 4 filings. For informational purposes only — not investment advice.